Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000527602 | SCV000634632 | likely benign | Familial aplasia of the vermis; Meckel-Gruber syndrome | 2025-01-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000999054 | SCV001155453 | uncertain significance | not provided | 2017-05-01 | criteria provided, single submitter | clinical testing | |
New York Genome Center | RCV001420616 | SCV001622939 | uncertain significance | Joubert syndrome 6 | 2020-06-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000999054 | SCV003915062 | uncertain significance | not provided | 2023-03-24 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV005044803 | SCV005675603 | uncertain significance | COACH syndrome 1; Joubert syndrome 6; Meckel syndrome, type 3; RHYNS syndrome; Bardet-Biedl syndrome 14; Nephronophthisis 11 | 2024-01-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004732934 | SCV005348528 | uncertain significance | TMEM67-related disorder | 2024-09-06 | no assertion criteria provided | clinical testing | The TMEM67 c.511G>A variant is predicted to result in the amino acid substitution p.Val171Ile. To our knowledge, this variant has not been reported in the literature in association with disease. It was reported in a control individual from a large study of focal segmental glomerulosclerosis (Table S4, Wang. 2019. PubMed ID: 31308072). This variant is reported in 0.14% of alleles in individuals of Ashkenazi Jewish descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |